Research & Development



  現在的局面跟設想中情況完全不同,渾邪王不出來,而這些算是手無寸鐵的匈奴人卻拿著各種稀奇古怪的武器跟羽林軍死扛,這都是為了什麼?   自從金日拿到了他成為馬監之後第一年的俸祿,他就將全家從長安城搬到了上林苑。亚州性夜夜射   上馬的時候,那個終于換上衣衫的胥吏想要隨他一起走,卻被隋越一鞭子抽在腦袋上,然後揚長而去。色大姐综合网   “里面有什麼?”   金日是在山包上開始憤怒的,當他一步步的走到山腳,臉上已經浮現了和煦的笑容。亚洲天堂a2018无码隔壁老王   楊文通依舊不肯罷休,努力的抬頭看著金日道︰“張公子已經安排好了一切,只要你現在罷手,我們還是可以幫你殺掉渾邪王,只要殺掉渾邪王,他的財物張公子答應分你半成!如此一來,你的族人就能過上好日子。想想啊,在大漢過上好日子是何等的艱難,只要你答應,死一個且靡胥不算什麼。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo